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Edited by Lukas HuberAbstract Ultraviolet-C (UVC) irradiation is a pathogen inacti-
vation method used for disinfection of pharmaceutical products
derived from human blood. Previous studies have shown that
UVC can potentially damage proteins through photolysis or
can generate reactive species resulting in protein thiol oxidation.
In this study, two ﬂuorescence-based quantitative proteomic ap-
proaches were used to assess the eﬀects of a novel UVC-disinfec-
tion strategy on human plasma fractions. We show minimal
changes in protein content, but gross alterations in protein thiol
reactivity, indicative of oxidative damage. We identify a number
of the damaged proteins by mass spectrometry, including serum
amyloid P component, and further demonstrate UVC-induced
photolysis of its disulphide bond.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Transmission of viruses present in human- or animal-derived
plasma and sera represents a considerable risk for recipients,
particularly when used as raw materials for the productionAbbreviations: UVC, Ultraviolet-C; 2-DE, two-dimensional gel
electrophoresis; 2D-DIGE, two-dimensional diﬀerence gel electropho-
resis; Cy2, 3-(4-carboxymethyl)phenylmethyl-3 0-ethyloxacarbocyanine
halide; Cy3, 1-(5-carboxypentyl)-10-propylindocarbocyanine halide;
Cy5, 1-(5-carboxypentyl)-10-methylindocarbocyanine halide; NHS,
N-hydroxysuccinimidyl; ICy, iodoacetylated cyanine dye; MS, mass
spectrometry; DTT, dithiothreitol; Chaps, (3-[(3-cholamidopropyl)-
dimethylammonio]-1-propanesulfonate); CCB, colloidal Coomassie
blue; ddH2O, double deionised water; AmBic, ammonium bicarbon-
ate; MALDI, matrix-assisted laser desorption/ionisation; TOF, time of
ﬂight; LC-MS/MS, liquid chromatography-tandem mass spectrome-
try; SAP, serum amyloid P component; ALB, albumin; RBP, retinol
binding protein; DTNB, 5,50-dithiobis-2-nitrobenzoate; CRP, C-reactive
protein
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teins and blood clotting agents. Therefore, procedures for inac-
tivating pathogenic viruses in these products are mandatory.
Conventional techniques used for pathogen inactivation in-
clude pasteurization, dry and vapour heat and solvent-deter-
gent treatments [1–3]. Ultraviolet irradiation was one of the
ﬁrst methods investigated in the pioneering years of biophar-
maceutical plasma fractionation, but soon proved ineﬀective
at preventing transmission of ‘‘serum hepatitis’’ [4]. Recently,
however, it has received renewed attention for its capability
to inactivate physically resistant non-enveloped single-
stranded viruses such as Hepatitis A and parvovirus B19
[5,6]. Flow-through reactors have been proposed and viral
reduction has been demonstrated using pathogenic viruses
and bacteriophages [1,7,8]. Although these disinfection strate-
gies can eﬀectively inactivate virus infectivity, some studies
have shown that UV treatment causes photo-damage to pro-
teins through disulphide photolysis and oxygen radical oxida-
tion [9–11]. While dose-dependent damage could be shown
with puriﬁed proteins [12], such eﬀects were not distinctly
apparent in protein mixtures such as prothrombin complex
concentrates. Such results raise concerns about the eﬀect of
UV-induced protein modiﬁcations on the biological activity
of these products, but more importantly, on their potential
toxicity.
Two-dimensional gel electrophoresis (2-DE) is one of the
most widely used proteomic separation methods and is often
employed for diﬀerential protein expression analysis of biolog-
ical samples [13]. Despite this, 2-DE is inherently variable and
the protein visualisation methods often used have narrow lin-
ear dynamic ranges of detection. A signiﬁcant improvement
came with the introduction of 2D-diﬀerence gel electrophoresis
(2D-DIGE), where co-detection of multiple ﬂuorescently la-
belled samples is possible on the same 2-DE gels, alleviating
the problems of gel-to-gel variation and improving the dy-
namic range of detection [14–16]. Conventional 2D-DIGE
methodology uses three mass and charge-matched N-hydroxy-
succinimidyl (NHS) ester-derivatives of the cyanine dyes 3-(4-
carboxymethyl)phenylmethyl-3 0-ethyloxacarbocyanine halide
(Cy2), 1-(5-carboxypentyl)-1 0-propylindocarbocyanine halide
(Cy3) and 1-(5-carboxypentyl)-1 0-methylindocarbocyanine ha-
lide (Cy5) for labelling the e-amine groups of lysine residues in
samples prior to mixing, 2-DE separation and multi-wavelengthblished by Elsevier B.V. All rights reserved.
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developed whereby alkylating forms of the Cy-dyes are used
to label cysteine thiol groups at higher stoichiometry [17]. In-
deed, our laboratory recently reported a pair of iodoacetyl cya-
nine (ICy) dyes and used them to monitor redox-dependent
thiol modiﬁcations and expression changes in a model cell sys-
tem exposed to hydrogen peroxide [18].
In the present study, the eﬀects of a novel Ultraviolet-C
(UVC)-irradiation strategy for treatment of the crude human
plasma fraction containing proteins of the prothrombin com-
plex are assessed [19]. It is possible that such treatment could
damage the protein components of this blood product aﬀecting
its potency or immunogenicity. A combination of lysine- and
cysteine-labelling 2D-DIGE and mass spectrometry (MS) was
thus used to determine if protein abundance and thiol reactivity
are altered in the plasma fraction following exposure to diﬀerent
UVC doses, which plasma proteins are targets of such UVC-in-
duced damage and what is the nature of this damage.2. Materials and methods
2.1. UVC treatment of plasma protein samples
UVC irradiation experiments were performed according to a valid-
atable method for determining a photochemically eﬀective dose suﬃ-
cient to inactive pathogens in a biological sample and enabling batch
irradiation (Patent application WO2004075931) [20]. Brieﬂy, 120 mL
of plasma fraction at a protein concentration of 15.5 g protein/L
(a253.7 = 7 cm
1) in a 4 cm diameter quartz glass test tube with a
magnetic stirrer was irradiated in a laboratory-scale batch reactor, illu-
minated with two individually switchable, water-thermostated, low-
pressure, mercury vapour lamps (253.7 nm). Irradiation is dependent
on the optical density of the test sample, average irradiance emitted
by the lamps and residence time in the irradiation chamber. In the
UVC irradiation experiments, a dose rate eﬀective in the solution of
3.186 mJ/cm2/min was achieved with irradiation times of 6 min 17 s,
12 min 34 s and 25 min 8 s for 20 mJ/cm2, 40 mJ/cm2 and 80 mJ/cm2,
respectively. Unirradiated fraction was used as a control. Puriﬁed ser-
um amyloid P component (SAP) and C-reactive protein (CRP) [21]
were irradiated at the indicated doses in a CL-1000 UV cross-linker
(Ultra-Violet Products) ﬁtted with 5 · 8 W 254 nm dual bipin dis-
charge type tubes.
2.2. Labelling of plasma proteins
NHS-Cy2 was purchased from GE Healthcare. NHS-Cy3/Cy5 and
ICy3/ICy5 were synthesised ‘‘in-house’’ and stored as described [18].
For NHS-Cy dye labelling, UV-irradiated and control plasma fractions
at 15 mg/mL were diluted to 1 mg/mL in denaturing 2D lysis buﬀer
(8 M urea, 2 M thiourea, 4% (w/v) (3-[(3-cholamidopropyl)-dimethyl-
ammonio]-1-propanesulfonate) (Chaps), 0.5% NP-40 (w/v), 10 mM
Tris–HCl, pH 8.3). Triplicate samples of 100 lg were minimally labelled
with 400 pmol of dye. Control samples and 20 mJ/cm2 UVC-treated
samples were labelled with Cy3 and Cy5, respectively. An equal pool
of all samples was also prepared and labelled with Cy2 as a standard
runon all gels to aid in spotmatching and cross-gel quantitative analysis.
Labelling was performed on ice in the dark for 1 h, reactions were
quenched with a 20-fold molar excess of free lysine to dye for 10 min,
and then dithiothreitol (DTT) added to 65 mM. For ICy labelling, plas-
ma fractionswere diluted to 1.5 mg/mL in ICy labelling buﬀer (8 Murea,
4% (w/v) Chaps, 10 mM Tris–HCl, pH 8.3) and 250 lg labelled with
20 nmol of ICy3/5 on ice in the dark for 1 h. Reactions were quenched
with DTT (to 65 mM). Labelled samples were mixed appropriately
and carrierAmpholines/Pharmalytes, pH3–10 (50:50 (v/v)) (GEHealth-
care) added to a ﬁnal concentration of 2%.
2.3. 2-DE, protein detection and image analysis
2-DE was performed using 18 cm, non-linear, pH 3–10, immobilised
pH gradient (IPG) strips (GE Healthcare) and 12% bonded gels exactly
as described [18]. Gels were scanned between low-ﬂuorescence glassplates using a Typhoon 9400 multiwavelength ﬂuorescence imager
and ImageQuant software (GE Healthcare) and gels post-stained with
colloidal Coomassie Blue G-250 (CCB). Images were curated, matched
and quantitative analysis performed using DeCyder software (GE
Healthcare) essentially as described [18]. Comparison of test spot vol-
umes with corresponding standard spot volumes gave a standardised
abundance for each matched spot and values were averaged across
triplicates for each experimental condition. Statistical analysis was per-
formed to pick spots matching across all images, displaying a P 1.5
average-fold increase or decrease in abundance between conditions,
and with P values <0.05 (Student’s t-test).
2.4. Spot picking, in-gel digestion and protein identiﬁcation by MS
Post-stained CCB images were matched with Cy dye images using
DeCyder software and a pick list of coordinates created for spots of
interest relative to a pair of reference markers ﬁxed to the glass plates.
Spots were excised using an Ettan spot picker (GE Healthcare). In-gel
tryptic digestion was performed exactly as described [22] and extracted
peptides resuspended in 6 lL of water. For peptide mass ﬁngerprint-
ing, 0.5 lL of tryptic digest was mixed with 1 lL of matrix (saturated
aqueous 2,5-dihydroxybenzoic acid) and spotted onto a sample target
plate and dried. Matrix-assisted laser desorption/ionisation; time-of-
ﬂight (MALDI-TOF) mass spectra were acquired using an externally
calibrated Ultraﬂex TOF/TOF mass spectrometer (Bruker Daltonics)
in the reﬂector mode. After internal calibration using trypsin autolysis
peaks, prominent peaks in the mass range m/z 500–5000 were used to
generate a peptide mass ﬁngerprint which was searched against the up-
dated NCBI database using Mascot version 2.0.02 (Matrix Sciences).
Identiﬁcations were accepted when a minimum of six peptide masses
matched a particular protein (mass error of ±50 ppm allowing 1 missed
cleavage), sequence coverage was >30%, MOWSE scores were higher
than the threshold value (P = 0.05), and the predicted protein mass
agreed with the gel-based mass. Nano-HPLC-electrospray ionisation-
collision-induced dissociation MS/MS was performed on an Ultimate
HPLC with a PepMap C18 75-lm inner diameter column (both LC
Packings) at a ﬂow rate of 300 nL/min, coupled to a Q-Tof (Micro-
mass) mass spectrometer. Spectra were processed using MassLynx
(Waters) software and submitted to Mascot database search routines.
Positive identiﬁcations were made when at least two peptide sequences
matched an entry and MOWSE scores were above the signiﬁcance
threshold value (P = 0.05).
2.5. Immunoblotting
Immunoblotting was used to validate expression of SAP in 20 lg
plasma fractions using an anti-SAP polyclonal antibody (Santa Cruz
Biotechnology) at a dilution of 1:1000. Both unlabelled and ICy3 la-
belled fractions were analysed. Enhanced chemiluminescence (Per-
kin–Elmer Life Sciences Inc.) was used for detection.
2.6. Quantitative determination of free thiols (Ellman’s test)
Measurement of free thiols was determined using Ellman’s reagent
[23]. Brieﬂy, 3.3 lL of 10 mM 5,5 0-dithiobis-2-nitrobenzoate (DTNB)
in 0.1 M sodium phosphate buﬀer (pH 8.0) was added to the indicated
amounts of control or UVC-irradiated puriﬁed human SAP diluted in
96.7 lL of the same buﬀer. The mixture was left to stand at room tem-
perature for 15 min in the dark. The absorbance was measured at
405 nm against a no protein reference and the concentration of sul-
phydryl groups was calculated using the equation: [SH] = [A412 (sam-
ple)  A412 (reference)]/13650.3. Results and discussion
3.1. Proteomic analysis of UVC-induced plasma protein damage
We assessed whether UVC-irradiation of a plasma fraction,
prepared as a pharmaceutical clotting agent, would result in
changes to the protein components of the sample, indicative
of protein damage. Lysine-labelling 2D-DIGE expression pro-
ﬁling was ﬁrst applied to assess changes in protein abundance
and/or isoform distribution following UVC treatment. Un-
treated and UVC-treated (20 mJ/cm2) fractions were diﬀeren-
Fig. 1. Visualisation of diﬀerential labelling of UVC-treated versus untreated plasma fractions using iodoacetyl cysteine labelling ICy dyes.
(A) Representative ICy dye images of UVC treated (right) and control (left) plasma samples. (B) Zoomed images of UVC-treated (right) and untreated
(left) fractions with protein spots displaying altered ICy-labelling. (C) Table showing average fold-diﬀerences in labelling intensity with P-values
between UVC-treated and untreated samples. (D) Venn diagram showing the number of spots and their altered labelling at diﬀerent UVC doses.
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labelled standard, comprising an equal mixture of both sam-
ples [14]. Image analysis revealed 11 signiﬁcant changes(>1.5-fold up- or down-regulated; P < 0.05) with some protein
spots present as trains of similar molecular weight, but diﬀer-
ent pIs indicative of post-translational modiﬁcations (data not
Table 1
Plasma fraction proteins displaying UVC-induced thiol reactivity changes
Spot no. Protein name % Cov MOWSE
Score
Est. mass Est. pl Pred.
mass
Pred. pl Accession
number
20 mJ/cm2
UVC vs. control
40 mJ/cm2
UVC vs. control
80 mJ/cm: 2
UVC vs. control
Function
Av. ratio P-value Av. ratio P-value Av. ratio P-value
11 Kininogen
precursor
35 81/64 70000 5.5 71945 6.3 125507 1.61 0.0059 1.75 0.003 2.13 0.0013 Blood coagulation
343 Thrombin
precursora;b
40 97/64 69000 5.3 71475 5.6 135807 2.21 0.00034 2.01 0.0011 2.32 0.00024 Blood coagulation
420 ALB proteinb 53 181/64 45000 6 47361 6 27692693 1.33 0.038 1.57 0.0012 1.86 0.00026 Carrier protein
433 Actin-b 31 67/64 43000 5.5 42188 5.4 15277503 1.7 0.0059 1.81 0.003 1.78 0.0069 Cytoskeletal protein
437 Complement
component C4
35 90/64 46000 7 48037 5.8 40737308 3.99 0.0036 3.47 0.0051 3.55 0.0043 Complement activation;
immunity
438 Complement
component C4
39 113/64 46000 7.5 48037 5.8 40737308 7.11 0.00048 5.65 0.00087 6.22 0.00082 Complement activation;
immunity
448 ALB proteinb 31 90/64 45000 5.9 48664 6 27692693 1.2 0.0051 1.49 0.0009 1.88 0.0002 Carrier protein
573 Thrombin
(fragment?)a
46 94/64 35000 7.5 34245 8.3 809450 1.15 0.0047 1.5 0.00075 1.74 0.000035 Blood coagulation
907 SAPa 39 90/64 24000 6 23358 6.1 576259 2.58 0.0058 3.86 0.0013 5.89 0.00049 Binding protein; innate
immunity
909 SAPb 39 107/64 24000 5.8 23358 6.1 576259 4.4 0.018 6.58 0.0068 13.41 0.00025 Binding protein; innate
immunity
913 SAP 39 112/64 24000 5.6 23358 6.1 576259 1.67 0.007 2.02 0.021 2.75 0.0067 Binding protein; innate
immunity
914 SAPa 33 70/64 24000 5.7 23358 6.1 576259 3.26 0.0047 5.96 0.00067 9.5 0.00031 Binding protein; innate
immunity
924 SAPa 39 78/64 24000 5.5 23358 6.1 576259 3.87 0.0024 6.2 0.00075 9.8 0.00031 Binding protein; innate
immunity
1072 Retinol binding
proteina,b
75 103/64 21000 5.5 20959 5.3 230284 1.87 0.0015 2.26 0.0006 4.09 0.000089 Vitamin A transport
Diﬀerentially labelled proteins form 2D-DIGE analysis were identiﬁed by MALDI-TOF peptide mass ﬁngerprinting and LC-MS/MS. The % coverage of analysed peptides, the MOWSE score from
Mascot searches and signiﬁcance threshold score, the estimated mass and pI (from gels), the predicted mass and pI (from the database) and the Accession number (NCBI gene identiﬁer) are shown for
each protein. Proteins displaying an average fold-diﬀerence of P 1.5-fold up (+) or down () regulation between pairs of conditions where P < 0.05 and where spots matched across all images are
italicised.
aProteins identiﬁed in two or more independent experiments.
bProtein identiﬁed by MALDI-TOF MS and LC-MS/MS.
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H.-L. Chan et al. / FEBS Letters 580 (2006) 3229–3236 3233shown). Repeat experiments using freshly prepared and irradi-
ated fractions also showed subtle changes in isoform distribu-
tion, although only two isoforms changed consistently between
experiments. It was noted that all changing spots were of rela-
tively low ﬂuorescence intensity and few could be aligned with
co-migrating CCB-stained spots. Multiple attempts to identify
these proteins by MALDI-TOF MS failed, likely reﬂecting the
low abundance of these isoforms. Thus, although UVC-irradi-
ation altered the abundance/distribution of several protein iso-
forms, these changes were subtle.
UVC radiation is known to modify protein cysteinyl thiol
groups [9–11]. We therefore applied a recently developed 2D-Fig. 2. Examples of protein isoforms identiﬁed by MS displaying UVC-ind
(C) serum amyloid P component and (D) retinol binding protein are shown. 3
treated (20, 40 and 80 mJ/cm2) samples. Graphs show changes in the standard
versus the corresponding standard gel feature). Triplicate data points are shDIGE methodology utilising iodoacetyl ICy dyes [18] to assess
UVC-induced changes in the thiol reactivity of the plasma pro-
teins. Experiments were conducted on UVC-irradiated samples
at doses of 0, 20, 40 and 80 mJ/cm2, in triplicate. Individual
ICy3-labelled samples were run on 2D gels against an equal
load of ICy5-labelled standard pool consisting of an equal
mixture of all samples to aid in spot matching and improve
the accuracy of quantitation. Around 1400 features were de-
tected with particularly strong labelling of a set of high molec-
ular weight acidic proteins (Fig. 1A). Twenty nine of these
features displayed signiﬁcant UVC-induced changes in label-
ling and with a high degree of overlap at the diﬀerent dosesuced changes in labelling. Data for (A) kininogen; (B) ALB protein;
D-images of gel features are shown for untreated (0 mJ/cm2) and UVC-
ised abundance of protein spots (ratio of the volume of a test gel feature
own with lines joining the average values.
Fig. 2 (continued)
3234 H.-L. Chan et al. / FEBS Letters 580 (2006) 3229–3236(Fig. 1B–D). CCB post-staining and matching with ﬂuores-
cence images allowed conﬁdent picking of 15 gel features, with
unpicked spots representing low-abundance isoforms.
3.2. Identiﬁcation of UVC-damaged plasma proteins
Fourteen of these proteins (representing seven gene products)
were identiﬁed by MALDI-TOF peptide mass ﬁngerprinting
and liquid chromatography-tandem mass spectrometry (LC-
MS/MS), with several displaying UVC dose-dependency in
ICy labelling (Table 1 and Figs. 1 and 2). All of the identiﬁed
proteins contain at least one cysteine, and since the ICy dyes
target reduced cysteinyl thiols, these results suggest that UVC
must alter the oxidative status of some of these thiol groups.
The diﬀerentially labelled proteins fell into several functional
groups including the blood coagulation and complement pro-
teins kininogen, thrombin and complement component C4.Kininogen is a thiol protease inhibitor which complexes with
prekallikrein and factor XI, which after cleavage by kallikrein
or factor XIIa, forms a disulphide-linked two subunit protein
with procoagulant activity. Kininogen displayed a dose-respon-
sive increase in ICy labelling following UVC irradiation
(Fig. 2A). Thus, its disulphide bridge must be broken to gener-
ate new thiol groups for ICy labelling. Two isoforms of the
disulphide-containing protease prothrombin were also found
in two spots, one at the expected mass of full-length prothrom-
bin (70-kDa) and the other a putative fragment (35-kDa)
which may correspond to the activated form. The two forms
displayed opposite ICy labelling responses following UVC
treatment (Table 1).
Albumin (ALB), a 48-kDa fragment of albumin, the major
binding/transport protein in serum, displayed a dose-depen-
dent reduction in cysteine labelling (Fig. 2B), suggesting that
Fig. 3. Validation of UVC-induced disulphide photolysis of SAP.
(A) The level of SAP in 20 lg of unlabelled and ICy3 labelled plasma
fraction in response to UVC-irradiation was assessed by immunoblot-
ting with an anti-SAP antibody. (B) Increased ICy labelling of puriﬁed
SAP after UVC irradiation. 500 ng of puriﬁed human SAP was
irradiated at the indicated doses of UVC and immediately labelled with
40 pmol of ICy3 prior to 15% SDS–PAGE. The ﬂuorescent image
(upper panel) and the corresponding CCB-stained image (lower panel)
are shown. (C) Quantitation of free thiol content of irradiated SAP
using Ellman’s reagent (see Section 2).
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links which may result in protein aggregation, as previously
observed [5]. Other serum transport proteins identiﬁed were
SAP and retinol binding protein (RBP), which displayed the
largest increases in ICy labelling (Table 1). SAP belongs to
the pentraxin family of Ca2+-dependent ligand binding pro-
teins, plays roles in host-defence by binding bacterial lipopoly-
saccharide, in amyloidogenesis by binding amyloid ﬁbrils and
is the major DNA- and chromatin-binding protein in plasma
[24]. In this study, several SAP isoforms were identiﬁed in a
charge train with all isoforms displaying increased labelling
with UVC dose (Table 1 and Fig. 2C). SAP contains a single
intramolecular disulphide bond [25], implying that UVC treat-
ment causes photolysis of this bond, creating sulphydryl
groups for ICy labelling. Although the multiple isoforms were
poorly focused, ICy labelling alone would not generate more
than two pI-shifted isoforms, indicating that formation of
the charge train is contributed by other modiﬁcations, possiblydiﬀerential glycosylation. RBP is the major retinol transporter
in plasma and its synthesis regulates retinol release from the li-
ver and uptake by target cells [26]. RBP contains six cysteines
forming three disulphide bonds, and like kininogen and SAP,
showed increased ICy labelling with UVC dose consistent with
photolysis and the generation of new thiol groups (Fig. 2D).
3.3. Validation of UVC-induced disulphide photolysis
SAP showed the greatest increase in ICy labelling following
UVC-irradiation and was therefore selected for further charac-
terisation. Immunoblotting of plasma fractions showed that
SAP protein levels were unaﬀected by UVC treatment,
although ICy3 labelling itself slightly reduced the protein level
at higher UV doses (Fig. 3A). Whilst this suggests that ICy3
labelling may aﬀect the solubility of SAP in plasma fractions
or reactivity to the antibody, it shows that the increased ICy
labelling observed in the 2D-DIGE experiment was not due
to a change in protein level, rather an increase in the thiol con-
tent of SAP. We next examined ICy labelling of irradiated
puriﬁed human SAP [21]. As with the plasma fractions,
UVC caused a dose-responsive increase in ICy labelling, con-
sistent with photolysis of the SAP disulphide bond (Fig. 3B).
Notably, a similar response was observed for puriﬁed human
CRP, a pentraxin family member closely related to SAP (data
not shown). To further conﬁrm disulphide photolysis and gen-
eration of new thiol groups, SAP samples were mixed with Ell-
man’s reagent and assayed for free thiol content. The assay
showed that 0.02, 0.18 and 1.43 mol/mol thiol/SAP were pres-
ent after 0, 80 and 320 mJ/cm2 UVC exposure, respectively
(Fig. 3C). Thus, UVC irradiation of SAP results in a signiﬁ-
cant proportion of disulphide photolysis, corroborating the
ﬁndings of the 2D-DIGE analysis. These data also suggest that
members of the pentraxin family have unique molecular struc-
tures/sequences that promote UVC-sensitivity.3.4. Conclusions
The ICy labelling data presented here, together with bio-
chemical, structural and photochemical data, support the
hypothesis that UVC induces the formation of free thiols in cer-
tain proteins through disruption of disulphide bonds. For SAP,
RBP and kininogen, this leads to a dose-responsive increase in
ICy labelling. The photochemical mechanism by which this is
likely to occur is through photolysis of disulphide bonds, which
in some cases might be favoured by absorption of UVC light
with the generation of solvated electrons through adjacent tryp-
tophan residues [27]. Photolysis may also promote the forma-
tion of new disulphide cross-links and possibly protein
aggregation which may explain the observed loss in ICy label-
ling of other proteins, such as complement component C4 and
ALB. Alternatively, UVC-induced reactive oxygen species
(ROS) or protein-derived peroxides may directly oxidise thiol
groups to form the sulfenic (–SOH), sulﬁnic (–SO2H) or sul-
fonic acid (–SO3H) forms of cysteine, which would not react
with the ICy dyes. Although previous work has shown that ﬂa-
vonoid antioxidants are able to protect plasma proteins from
UVC irradiation damage [5,6], these compounds are also eﬀec-
tive as scavengers of solvated electrons as well as ROS. Thus,
the contribution of either pathway to the mechanism of photo-
chemical damage remains to be elucidated.
It is important to note that none of the aﬀected ICy-reactive
proteins showed changes in lysine labelling, indicating that
3236 H.-L. Chan et al. / FEBS Letters 580 (2006) 3229–3236there were no gross changes in protein abundance, for example
due to peptide backbone photolysis or aggregation and precip-
itation. Despite the possible molecular damage to the coagula-
tion factors thrombin and kininogen, our previous work has
shown that UVC irradiation does not signiﬁcantly alter the
clotting activity of our plasma fractions or, in contrast to ear-
lier reports, the overall free thiol level (data not shown) [28].
Apart from SAP, our own observations may suggest that the
photolytic and oxidative damage occurs at low-stoichiometry,
supporting the only modest eﬀects on protein abundance.
However, even limited modiﬁcations may be of concern as
the breakage or formation of disulphide bonds may adversely
aﬀect the structure and biological activity of these proteins.
More important than loss of bioactivity is whether these mod-
iﬁcations are toxic, and as such it remains to be proven if they
represent a danger to patients receiving UVC-disinfected coag-
ulation factor concentrates.
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